STAT Wunderkind Sydney Ramirez is revealing the immune system in our nasal passages and working toward better disease ...

CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo” or the “Company”), an innovative cellular immunotherapy company, ...

Preclinical data support Abalos’ first-in-class approach of safely harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to treat solid tumors -- Düsseldorf, Germany, October 14 ...

Study’s Dose Escalation Safety Committee approves initiation of Cohort 2 with fourth patient to receive increase in initial dose pending ...

This review examines how Western dietary patterns, high in ultra-processed foods, salt, and unhealthy fats, disrupt gut ...

Abstract: This study explores the development of an AI-driven adaptive laser bird deterrence system, aiming to enhance bird deterrence efficiency and adaptability through the integration of artificial ...

Investing.com -- CERo Therapeutics (NASDAQ:CERO), a T cell therapy biotech company, is open to licensing deals or a potential sale while awaiting data on its lead asset, according to Axios, citing CEO ...

Seven UCSF investigators are receiving the prestigious award for their research from the National Institutes of Health.

A next-generation cancer vaccine has shown stunning results in mice, preventing up to 88% of aggressive and ...

The super adjuvant vaccine also protected against the spread of cancer to the lungs. When exposed to melanoma cells systemically, which mimics how cancer metastasizes, none of the ...